PML therapy: “It's Déjà vu all over again” Kenneth L. Tyler Editorial 03 August 2013 Pages: 311 - 313
Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways F. B. Del GuerraJ. L. I. FonsecaE. Castelon Konkiewitz Review 19 July 2013 Pages: 314 - 327
Immunological control of herpes simplex virus infections Kevin P. EganSharon WuStephen R. Jennings Review Open access 14 August 2013 Pages: 328 - 345
Recent issues in herpes simplex encephalitis Peter G. E. KennedyIsrael Steiner Mini Review 18 June 2013 Pages: 346 - 350
A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes David B. CliffordAvindra NathPetra Duda OriginalPaper Open access 04 June 2013 Pages: 351 - 358
High levels of divergent HIV-1 quasispecies in patients with neurological opportunistic infections in China Yulin ZhangFeili WeiDexi Chen OriginalPaper 10 July 2013 Pages: 359 - 366
In vivo differential susceptibility of sensory neurons to rabies virus infection Myriam L. Velandia-RomeroJaime E. CastellanosMarlén Martínez-Gutiérrez OriginalPaper 20 August 2013 Pages: 367 - 375
Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt study Matteo VassalloBrigitte DunaisChristian Pradier OriginalPaper 12 July 2013 Pages: 376 - 382
Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect Birgit GrundEdwina J. Wrightfor the INSIGHT SMART Study Group OriginalPaper 14 August 2013 Pages: 383 - 392
Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection Christine Fennema-NotestineRonald J. Ellisfor the CHARTER Group OriginalPaper 10 July 2013 Pages: 393 - 401
CSF viral escape in a patient with HIV-associated neurocognitive disorder Michael N. KhouryC. Sabrina TanIgor J. Koralnik Case Report 05 June 2013 Pages: 402 - 405
